Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Tenax Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q2 2023
- Shares held
- 623.9K
- +224.9K (+56.4%) vs. Q2 2023
- Total value
- $184.8K
- +$65.6K (+55.0%) vs. Q2 2023
- New holders
- 4
- 2 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Cantonale Vaudoise | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Tucker Asset Management LLC | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 160 | $48 | 0.00% | +2+1.3% | Added |
| Morgan Stanley | 675 | $202 | 0.00% | −5−0.7% | Reduced |
| Tower Research Capital LLC (TRC) | 4,653 | $1.39K | 0.00% | −14−0.3% | Reduced |
| Lido Advisors, LLC | 10,000 | $2.99K | 0.00% | +10,000 | New |
| Avantax Planning Partners, Inc. | 10,002 | $2.99K | 0.00% | −5,000−33.3% | Reduced |
| Citadel Advisors LLC | 15,033 | $4.43K | 0.00% | +15,033 | New |
| LPL Financial LLC | 20,000 | $5.98K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 23,922 | $7.15K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 36,799 | $11.0K | 0.00% | +36,799 | New |
| State Street Corp | 95,122 | $28.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 97,037 | $29.0K | 0.00% | +77,273+391.0% | Added |
| Geode Capital Management, LLC | 118,978 | $35.1K | 0.00% | +118,978 | New |
| CI Private Wealth, LLC | 191,460 | $56.4K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | – | – | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −16,564−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,577−100.0% | Sold out |
| Horan Securities, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |